Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
138.00
Ask:
144.50
Spread: 6.50 (4.71%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board Changes

31 May 2023 09:00

RNS Number : 0914B
Xaar PLC
31 May 2023
 

31 May 2023

 

Xaar plc

 

Board changes

 

Xaar plc ("Xaar" or "the Group" or "the Company"), the leading inkjet printing technology group, announces the appointment of Richard Amos as Non-Executive Director.

 

Richard joins the Board with effect from 1 June 2023 and on appointment will replace Chris Morgan as Chair of the Audit Committee and be a member of the Remuneration and Nomination Committees. In accordance with the Board's succession plan disclosed in the 2022 Annual Report, Chris Morgan intends to stand down as a Non-Executive Director of the Company by the end of 2023.

 

Richard is a qualified Chartered Accountant with over 30 years' experience, having started his career at EY in 1988. From 2000 to 2020, he served as an executive on the boards of five companies listed on the London Stock Exchange, most recently as Chief Financial Officer of Wilmington plc, Chief Financial Officer of Plant Impact plc and Group Finance Director of Anite plc. He is currently a Non-Executive Director at Thruvision Group plc (AIM: THRU), where he serves as the Senior Independent Director, Chair of the Audit and Nomination Committees and is a member of the of the Remuneration Committee. Richard is also the Non-Executive Chairman of Skillcast Group plc (AIM: SKL). 

 

In 2022 the Board reviewed its succession plan and revised its policy on board diversity, reinforcing the intention to recruit and maintain a diverse board with a strong skills mix. The Board plans to recruit a further Non-Executive Director during 2023 and remains committed to building a diverse board.

 

Andrew Herbert, Chairman, commented:

 

"As we actively manage succession, we are delighted to welcome Richard to the Board who brings complementary skills and experience and will make an immediate impact in taking over as chair of the Audit Committee. The Board remains committed to its policy on diversity and we anticipate making a further appointment later in the year. I would like to thank Chris for his time as chair of Audit during a particularly challenging period and thank him for his ongoing support during the remainder of his tenure.

 

The Company confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to the appointment of Richard Amos.

 

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURORROVUVOUR
Date   Source Headline
13th Mar 20094:35 pmRNSPrice Monitoring Extension
6th Mar 20099:00 amRNSHolding(s) in Company
4th Mar 20097:00 amRNSNotice of Final Results
24th Feb 20097:00 amRNSNew product launch
18th Feb 200912:15 pmRNSDirector/PDMR Shareholding
16th Jan 20093:45 pmRNSHolding(s) in Company
15th Jan 20097:00 amRNSFull Year Trading Update
14th Jan 20093:00 pmRNSHolding(s) in Company
7th Jan 20094:15 pmRNSHolding(s) in Company
7th Jan 20099:00 amRNSHolding(s) in Company
23rd Dec 20083:57 pmRNSHolding(s) in Company
16th Dec 20084:40 pmRNSSecond Price Monitoring Extn
16th Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20083:10 pmRNSDirector/PDMR Shareholding
28th Nov 20089:00 amRNSDirector/PDMR Shareholding
26th Nov 20087:00 amRNSTrading Update
24th Nov 20084:40 pmRNSPrice Monitoring Extension
12th Nov 20084:05 pmRNSDirector/PDMR Shareholding Replacement
12th Nov 20083:03 pmRNSDirector/PDMR Shareholding
21st Oct 20089:00 amRNSHolding(s) in Company
15th Oct 20087:00 amRNSInterim Management Statement
13th Oct 20084:41 pmRNSSecond Price Monitoring Extn
13th Oct 20084:36 pmRNSPrice Monitoring Extension
30th Sep 20087:00 amRNSNotice of IMS
5th Sep 200810:00 amRNSBlocklisting Interim Review -
5th Sep 20089:08 amRNSBlocklisting Interim Review
4th Sep 20089:00 amRNSHolding(s) in Company
3rd Sep 20084:14 pmRNSDirector/PDMR Shareholding
28th Aug 200810:27 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSHalf Yearly Report and Result
6th Aug 20087:00 amRNSNotice of Half Year Report
29th Jul 20089:39 amRNSHolding(s) in Company
25th Jul 20081:46 pmRNSHolding(s) in Company
15th Jul 200810:46 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSPeriod end update & new broke
5th Jun 20086:00 pmRNSTotal Voting Rights
30th May 20087:00 amRNSAnalyst/investor visit to Dru
23rd May 20087:00 amRNSChina business update: recent
15th May 20082:49 pmRNSHolding(s) in Company
14th May 200810:10 amRNSDirectorate Change
13th May 200812:04 pmRNSResult of AGM
13th May 200812:04 pmRNSResult of AGM
13th May 20086:00 amRNSInterim Management & AGM Stat
9th May 200811:48 amRNSTotal Voting Rights
29th Apr 20082:23 pmRNSDirector/PDMR Shareholding
28th Apr 20084:35 pmRNSHolding(s) in Company
28th Apr 20087:00 amRNSDrupa exhibition preview
10th Apr 20083:50 pmRNSAnnual Information Update
2nd Apr 20085:43 pmRNSTotal Voting Rights
27th Mar 20086:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.